MYSTERIOUS: Do wall street analysts like gilead sciences stock | Mind Blowing Facts

Foster City, California-based Gilead Sciences, Inc. (GILD) is a leading biopharmaceutical company. It discovers, develops, and commercializes medicines in the areas of unmet medical needs. With a market cap of $95.6 billion, Gilead’s operations span the U.S., Europe, and internationally.

The pharma giant has substantially underperformed the broader market over the past year. The GILD stock is up 1.4% over the past 52 weeks, while the S&P 500 Index ($SPX) has rallied 18.5% over the same time frame. In 2024, Gilead stock dipped 5.2%, while the $SPX returned 12.1% on a YTD basis.